Acticor Biotech
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo (NCT05070260) | Acticor Biotech | 2021-09-23 |
| Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 (NCT04659109) | Acticor Biotech | 2020-12-16 |
| Acute Ischemic Stroke Interventional Study (NCT03803007) | Acticor Biotech | 2019-03-06 |
Track Acticor Biotech automatically
Every clearance here is in the API, with alerts when new ones post.